Dynamic Purchasing System for Ongoing and Repeated Purchases of Medicinal Products – January_5/2025 - Nivolumab

This public contract concerns the ongoing supply of the medicinal product containing the active substance NIVOLUMAB, based on individual orders from the contracting authority. This is a recurring contract under the "Dynamic Purchasing System for Ongoing and Repeated Purchases of Medicinal Products – December_2/2024 - NIVOLUMAB." The procurement aims to establish a framework for the continuous acquisition of this specific pharmaceutical. Should multiple bids meet the tender conditions, their evaluation will be conducted through an electronic auction within the TENDER BOX system. This dynamic purchasing system is designed to streamline and expedite the procurement process for essential medicines, ensuring timely availability for healthcare needs. The contracting authority seeks reliable suppliers capable of meeting the demand for Nivolumab, a critical medication. The system allows for flexibility and efficiency in managing repeated purchases, adapting to evolving needs while maintaining competitive pricing through electronic auctions. Interested parties are expected to demonstrate their capacity to supply Nivolumab in accordance with the specified quality standards and delivery timelines. The contract duration and specific quantities will be detailed in the subsequent individual orders placed through the dynamic purchasing system.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Czech Republic, Europe, this opportunity is open to firms and consortiums, with an estimated budget of CZK 469.3 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.